
CASE DISCUSSION
Infective Endocarditis: Diagnosis and Management
Views
14,398
Credit Points
Learning Hours
CPD Points
CME Points
Courses Completed
Case Description
Infective endocarditis (IE) carries a high risk of morbidity and mortality. Rapid diagnosis, effective treatment, and prompt recognition of complications are essential to good patient outcomes. Therapy of IE caused by the more commonly encountered organisms, including streptococci, enterococci,...
Case Summary
- Infective endocarditis arises when endothelial injury, stemming from conditions such as rheumatic heart disease, congenital anomalies, or prosthetic material, fosters nonbacterial thrombotic endocarditis that subsequently becomes colonized during transient bacteremia. Clinical presentation ranges from an acute, fulminant course typically caused by virulent pathogens like Staphylococcus aureus—frequently seen in intravenous drug users and on structurally normal valves—to an indolent, subacute course classically driven by Streptococcus viridans. Coagulase-negative staphylococci dominate early prosthetic valve infections, while the fastidious HACEK group, fungi, or prior empiric antibiotic exposure may cause culture-negative endocarditis.
Speaker Profile

Dr. Naresh Kumar
Consultant Cardiothoracic Surgeon, AIG hospitals, Hyderabad
Disclosures
Assimilate by Medvarsity requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.